Rocket Pharmaceuticals Inc - Common Stock (RCKT)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
108,294,335
Total 13F shares
62,013,212
Share change
-194,382
Total reported value
$2,752,442,865
Put/Call ratio
263%
Price per share
$44.37
Number of holders
169
Value change
-$22,930,130
Number of buys
93
Number of sells
80

Institutional Holders of Rocket Pharmaceuticals Inc - Common Stock (RCKT) as of Q1 2021

As of 31 Mar 2021, Rocket Pharmaceuticals Inc - Common Stock (RCKT) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,013,212 shares. The largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, and LORD, ABBETT & CO. LLC. This page lists 169 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.